Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Lets Talk About PrEP

Lets Talk About PrEP artwork

Let's Talk About PrEP – Season 2, Episode 3: Darwin Thompson

Aug 26, 202618 minAudio
ShareXLinkedInFacebookWhatsAppEmail

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Transcript

From the show. Tap a time to play from there.

SPEAKER_01From Talking, this is Let's Talk About Prep, a podcast about the people of Hyper Prevention, from scientists developing prevention tools, a community leader supporting their peers to advocates using their voices to create things. This episode brings to conversation with the people moving the field forward. I'm your host, Wanna Gandhi. Let's talk about prep. Today on Let's Talk About Prep, we have Darwin Thompson. He brings more than 15 years of experience advancing equity through public affairs and community-based work.

SPEAKER_01Darwin Thompson serves as corporate social responsibility director at Gilead Sciences. As the corporate social responsibility director at Gilead Sciences, Thompson focuses on the pharmaceutical company's efforts to integrate social, environmental, and ethical concerns into their business model. His career has focused on supporting marginalized communities through HIV prevention, grant making, and program development, including serving as executive director of a community-based nonprofit in Atlanta. Darwin, thank you so much for joining us here.

SPEAKER_00I'm so excited to be here. Thank you for having me.

SPEAKER_01What are some of the lessons that you've learned that a more corporatized workspace, such as a bank or anything else in that structure would not have taught you that the HIV prevention space and community programs have taught you?

SPEAKER_00I think that's a really good question. One of the biggest things that I've learned is that the community has the answer, right? And so when we ground ourselves with everything from a community-focused lens, allow the community to be to be the experts, um that you see progress faster. But the other caveat to that is when you're when you're in these institutions, um not having those individuals who work in your institutions be your only lived experience, right? Um you hire them because they are because of their worth, their expertise, but they're not the only experts.

SPEAKER_00And so oftentimes these corporations hire individuals who might identify as black, gay, or whatever, um, and they want them to be their subject matter experts versus actually bringing in the people who are on the ground with the lived experience who may actually have a different perspective in front of the view that can accelerate progress faster.

SPEAKER_01I mean, let's talk about the real needs of marginalized communities, in as much as you are in this big institution such as Killiard Sciences that focuses on pharmaceutical. What is it that you bring into that space and being a voice for marginalized communities as you serve in that title of corporate social responsibility?

SPEAKER_00Yeah, I mean, when I bring my lived experience, my lived experience, it's just not about how I identify. I bring the experience of running a nonprofit, I bring the experience of um applying for resources, I bring the experience of managing teams, I bring the experience of developing programs. And so I bring sort of the lived experience that sometimes um corporate structures don't have from a from a community-facing lens. Um, but I also bring, I also, you know, I like to say I work and live within my community, right?

SPEAKER_00And so um I also bring that where I am, I am who I am, and so oftentimes um, you know, you look at it, there's this, there's this perfect imbalance where you are like you're in this corporate structure, but also um you you need to engage and and live within sort of the communities that you are that you're working so hard to do. So you try to find that balance.

SPEAKER_01Why is it important for community voices to be echoed within those corridors? Corridors of power, corridors of decision making.

SPEAKER_00Because I think these institutions are working on behalf of the community, right? Um at the end of the day, whether it's a pharmaceutical company, whether it's your your big box retailer, whether it's your local, um, whether it's your local clothing store or whatever, communities are are accessing your services or accessing your products. And so if you're not putting or thinking about the community, then your your runway um for future growth, for future partnership is limited.

SPEAKER_00And so I think you always have to think about what the community needs. Um, I understand that there's a there's business objectives and business goals, but I think if you continue to put community first or to incorporate them into your strategy, then I ultimately think that you have you'll have more uh long-term success.

SPEAKER_01Let's talk about how best um pharmaceutical companies can can support communities beyond just creating the medication itself.

SPEAKER_00Yeah, I mean, I think, you know, I think it's resources. I think it's resources to ensure those um who can access or who have limited access can access um potential products. I think it's human capital. Um, oftentimes, I think it's, you know, you think about the financial, the financial gains. I think it's about um sometimes maybe pairing um a researcher with the community organization or um someone from their HR department to think about you know HR policies, finance management, those sort of things.

SPEAKER_00I think some of the best and brightest people work within these institutions, and they're not they aren't necessarily on the front lines in a for in a forward-facing role. They're the ones that are behind the scenes. And I think oftentimes we look we look at these companies and like it's the it's the money aspect, um, which I think communities need, but it's these other technical and capacity building things that I think these institutions have that if we really partnered well, that um that I think could move those community organizations forward in a more in a in an accelerated fashion.

SPEAKER_01I think the the most common word that we hear um from from community members, especially from from my place, my country, Zambia, my continent, Africa, is the word big farmer, right? As you've spoken about the money-making aspect where there isn't a a community-to-company relation, there isn't a face upfront seeing who we are serving, but just seeing a community as a commodity that purchases these products and services from us.

SPEAKER_01Let's talk about the misconceptions then that we might have as marginalized communities about organizations that are are much more inclined to pharmaceutical services. What are some of the misconceptions?

SPEAKER_00I think the misconception, the biggest misconception is there are individuals who are working on behalf of communities on the inside every day, advocating and voicing opinions and and and and pushing the system, right, to ensure that the voices are heard. Um I think the a misconception, I think another big misconception is that um is that when you really think about the big pharma that that really that the people don't care.

SPEAKER_00And I think that's I and it's about profit, and I think that's the absolute wildest misconception is that I I'm in so many meetings, I talk to so many people who are who don't look like us, but who are trying to make sure that the communities are seeing their value, that the resources get to them. Um and it's difficult, but you often like we often oh they don't care, and I'm like, oh my God. The 18,000 employees that that I work colleagues that I work with all care. Um, and so I think that's the biggest misconception is that that we don't care in reality.

SPEAKER_00Being on the inside, I'm like, oh, okay, I see it. Um I see that everyone here cares, everyone is here because of the mission, everyone is here because of the purpose. Um, and I think sometimes I get that gets lost because we don't necessarily share it out. Um, but I think like I think that the people internally care so much about community, both in the US and globally. Um, and I think that's the thing that that the biggest misacception that I don't think community really accepts or appreciates.

SPEAKER_01I mean, many people still struggle to access HIV prevention tools because of stigma, the cost or lack of information thereof. What do you think are the biggest barriers today?

SPEAKER_00Yeah, I mean, I think you know, research shows that, you know, cost may not be as prohibitive of a barrier as we think it might be, um, especially in the US. Um I think that stigma is the number one cause of people not accessing either prevention or treatment medications, right? Um, it is the stigma, they're all internalized stigma. Um, it is whether you're in a in a rural city in in the US, and if you go to the local health department, member of your family works there.

SPEAKER_00So you don't want them to know that you're living with um with HFIB, so you don't go. Or because you don't go, you have to now travel an hour back and forth um to another clinic and you don't have the resources to do so. So I think stigma is the domino effect into um why a lot of people are engaged into care. Um I also think that like, especially when it comes to prevention, I think we're just being caught up when it comes to prevention, right? I think, especially from a person of colored lens, um, you know, we didn't it we did not know um when it first came out that we could access it.

SPEAKER_00We were educated about it. Um, and so I think we are being caught up around, you know, prevention tools. Um, and I think we need to continue to do a job, uh, we need to continue to educate and accelerate that education and information to communities. Um because I think that there's still, I still talk to people almost every day who are like, well, I didn't know this existed. And I and I'm like, wow, it's 2026. As many times as I see a commercial or this or that, and you're still saying, I didn't know this existed, or I don't know how to that this was for me, I think it's problematic.

SPEAKER_01I mean, in your role at Gilead, you sort of bring that link between a nonprofit facing and much more of a corporate-facing institution, and you walked the corridors of nonprofit and corporate spaces. How important is it for communities, governments, and different stakeholders and private companies to work together in the fight against HIV?

SPEAKER_00Oh, I think public-private partnerships are important. Um, it isn't, I think if we like we will never get to our goals of ending HIV epidemic if we don't work together. Um, that's government entities, that's that's that's pharmaceutical companies, that's community-based organizations, that's advocates, those are non-traditional partners, right? I think again, if we take a diagnosis away from an individual, right, and we just humanize them as a person, they're the individuals who vote for you, they're the individuals who access services at your restaurants, they're the ones that shop with you.

SPEAKER_00The list goes on. And so sometimes I think we minimize people um to their diagnosis, and we don't humanize them to understand that outside of their diagnosis, they are some of the main reasons why the why the engine of the country goes, while the engine of the company moves, they're some of the main reasons why um, you know, products are coming off the shelves. And so if we think about that from a broader perspective and just not about a diagnosis, then you start to connect the dots with like, wow, this individual is part of the ecosystem, um, and we need to be we need to figure out how to support them.

SPEAKER_01I mean, and change is is a two-way system. It's about in as much as you are a part of Gilead in this space, and you are sort of like the bridge in the corporate social responsibility aspect of the organization, at the same time, you are educating community and educating the firm itself about their views, different views, and different perspectives. What is it that you feel in general the pharmaceutical companies got wrong about communities when you first stepped into those spaces?

SPEAKER_00That every community is the same, that you can do everything for everyone. I think that we need to individualize things. And I mean, if I just speak from a US perspective, you know, what we do in an urban city, we may not be able to do in a rural city. And sometimes I think we try to package everything for everyone, and we cannot do that. Um, I think we have to figure out interventions that are, we have to tailor interventions and programs for those. I think you have to go where the, I think, yeah, and that means you have to go where the need is greatest. Um, and I think that, you know, yeah, I'll say that.

SPEAKER_00I think that's I think that's the the biggest thing is like communities aren't a monolith. You have to you have to create tailored interventions for them to really to really make progress.

SPEAKER_01And how in this case can companies engage communities without feeling transactional, for lack of a better term.

SPEAKER_00Yeah, I mean, I think I think companies can engage communities like one, pay them, pay them as subject matter experts, pay them for their expertise. Um we often do like advisory boards to help inform strategies. I think companies can bring them in at the beginning, right? Um, of strategy development and say, hey, this is what we're thinking. Um, would it resonate with with community, right? But then the flip side of it is once you create the strategy based on the feedback of the of the community, go back to the community and say, this is what we heard, and this is what we're doing before we do it.

SPEAKER_00So that is a two-way street and it's bilateral, and it just doesn't seem like you know, we're creating things in an ivory tower, um, and we're just saying, hey, accept this. But no, it was really informed by community. Um, this work is very important. Um, the people who work in this work every day are part of the community, and they should be at the table, whether they work at the company or not, they should be at the table helping to inform, helping to advise when possible.

SPEAKER_01What does accountability look like for black communities? Black communities that are marginalized, black communities that are LGBTQ. What does that look like in practice?

SPEAKER_00I mean, I think accountability looks like, I mean, from a from a from a a micro perspective, like just doing what you say you're gonna do. Um, you know, if things aren't going the way that they should be going, that you communicate that. I think community has to be held accountable to the people that they're serving, right? And so that means being culturally competent. Um, that means um that means being culturally competent, that means um providing the best services.

SPEAKER_00Um we have B back around services. So I think it's similar to the the to what farm to a big what what companies should be doing. I think also community has to think about how they put the patient and the client first.

SPEAKER_01Many young people are coming in and what would like to create change in public health or community advocacy, or albeit develop programs that speak to the needs of communities, not only in the US, not only on the African continent, but globally. What advice do you have for them?

SPEAKER_00Do it. Some of the best programs that I've seen have come from young people. That's what's important. I think oftentimes, you know, they feel like their voices are heard. Um, and I think you're I think young people are a powerful tool to ending the HIV epidemic. They're some of the most creative, um, some of the most innovative, some of the most smartest people that I've that I come that I come across. And what happens is we don't give them an opportunity to create, or they feel like they can't do it.

SPEAKER_00And so my biggest advice to young people is do it. Write that grant, talk to that funder, start that organization, and just do it.

SPEAKER_01Darwin, thank you so much for joining us on Let's Talk About Prep. It was an honor to listen to you speak about your experience uh within the corporate space, within the nonprofit space, and just echoing on what role many young black African minority uh persons could take up in the fight against HIV. What does the future look like in closing from where you stand?

SPEAKER_00I mean, I've said this since I got into this field in 2009, 2008. I want to see a, I want to, I want there to be a day where myself personally, I work myself out of a job. I want to see a day where we no longer need um HIV advocates because we ended this thing. I want to see a day where people have access. Um I want to see a day where we I want to see a day where there's HIV AIDS regeneration.

SPEAKER_00And I do believe that we have we have the ability to do that within our lifetime. Um it's gonna take me, you, we, all of us to work together um for a common to that common goal. Um and so that's what I really want to see. I want to see the day when I no longer say I work in HIV prevention because we ended this thing.

SPEAKER_01You've been listening to Let's Talk About Prep, brought to you by GBGMC. I'm your host, Wanzi Anji. Thank you for joining us. Until next time, stay informed, stay connected, and keep the conversation going.

Open the transcript file

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Lets Talk About Sex Episode 5 with Chivuli Ukwimi

    Nov 16, 202624 minAudio

    Human Rights at the heart of HIV Prevention

    Credit the people on this episode

  2. Episode 4: Community Leadership Driving Change — Josephine Aseme

    Oct 9, 202652 minAudio

    Credit the people on this episode

  3. Let's Talk About PrEP – Season 2, Episode 2: The Future of HIV Prevention with Mitchell Warren

    Aug 5, 202635 minAudio

    Credit the people on this episode

  4. Let's Talk About PrEP – Season 2, Episode 1: Reimagining HIV Prevention with Prof. Linda-Gail Bekker

    Jul 10, 202631 minAudio

    Let's Talk About PrEP - Season 2, Episode 1: Reimagining HIV Prevention with Prof. Linda-Gail Bekker Season 2 of Let's Talk About PrEP begins with one of the world's leading voices in HIV science and prevention, Prof....

    Credit the people on this episode

  5. Lets Talk About Sex Episode 5 with John Meade, MPH

    Oct 23, 202550 minAudio

    Credit the people on this episode